Completed PHASE4 INTERVENTIONAL 1-arm NCT02568488

The Effect of Metformin on Different Hormones in PCOS Patients

The Effect of Metformin on Serum Insulin, Androgens and AMH in PCOS Patients

Sponsor: Ahmed Maged

Interventions Metformin

Updated 6 times since 2017 Last updated: Mar 19, 2017 Started: Mar 31, 2014 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02568488, this PHASE4 trial focuses on Polycystic Ovarian Syndrome and remains completed. Sponsored by Ahmed Maged, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ahmed Maged

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.